KIRK WILLIAMSON: Open Payments
NPI 1821449372 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 79 payments from 18 companies in 2025. Trend: 2023 $1,365 · 2024 $2,320 · 2025 $1,336
Food & beverage: $1,316Education: $20
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $243 |
| Novartis Pharmaceuticals Corporation | 23 | $208 |
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| Alnylam Pharmaceuticals Inc. | 5 | $150 |
| Novo Nordisk Inc | 9 | $149 |
| Organon LLC | 1 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| CVRx, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $21 |
Products named: VYNDAQEL, WAINUA, LEQVIO, AMVUTTRA, Wegovy, VTAMA, ELIQUIS, JARDIANCE.
Industry payments across AR — which companies pay providers there.
